These names look poised to make a move in the coming days.
This Stock Looks Poised for a Breakout in the Short-Term
by •
Our target potential upside is 14%-23% in the next 3-6 months
Upgrades and Downgrades for Monday, 11/13
by •
Here are today’s upgrades and downgrades: Oracle, Crowdstrike, HP Inc., International Flavors & Fragrances, Southwest, TripAdvisor, Oshkosh and more.
You’ll Regret Not Buying This Growth Stock on the Dip
by •
After crushing top and bottom quarterly earnings, it sits 47% below its all-time high which presents an opportunity.
This Dividend Aristocrat Hasn’t Been This Cheap in Years
by •
While the bears think they have a strong case for selling, a closer look suggests it still has a lot to offer investors, including a huge global scale and tremendous brand power.
3 Stocks Poised to Outperform the Market
by •
These three earnings season winners might be worth checking out before the rest of the market jumps in.
This Stock Just Broke Out with High Volume
by •
Here’s how to trade it with a target potential upside 11%-21% in the next 3-6 months.
Upgrades and Downgrades for Friday, 11/10
by •
Here are today’s upgrades and downgrades: Occidental Petroleum, Plug Power, Southwest, CarMax, Diebold, BJ’s Wholesale, American Airlines and more.
If I Could Only Buy 1 Stock, This Would Be It
by •
Offering a rare combination of unbelievable growth at a reasonable price, while there is some risk, the upside is too great to ignore.
3 Biotech Stocks With the Strongest Clinical Pipelines
by •
Recession-proof, and still one of the most exciting sectors on the market, biotech stocks are thriving with millions of retiring baby boomers, mergers and acquisitions, new innovation and the introduction of AI.